ImportRefusal LogoImportRefusal

Assia Chemical Industries Ltd - Teva Tech Site

⚠️ Moderate Risk

FEI: 3002913672 • Be'Er Sheva • ISRAEL

FEI

FEI Number

3002913672

📍

Location

Be'Er Sheva

🇮🇱

Country

ISRAEL
🏢

Address

Neot Hovav Eco-Ind. Park, Emek Sara, Be'Er Sheva, , Israel

Moderate Risk

FDA Import Risk Assessment

44.5
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

14
Total Refusals
2
Unique Violations
8/2/2016
Latest Refusal
9/21/2004
Earliest Refusal

Score Breakdown

Violation Severity
75.7×40%
Refusal Volume
43.6×30%
Recency
0.0×20%
Frequency
11.8×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

1610×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

754×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
8/2/2016
66NCS04RISPERIDONE (TRANQUILIZER (ANTI-PSYCHOTIC) - PART II)
16DIRECTIONS
Philadelphia District Office (PHI-DO)
8/3/2015
66SCS51TADALAFIL
75UNAPPROVED
Philadelphia District Office (PHI-DO)
7/3/2013
62TCS07PANTOPRAZOLE SODIUM
16DIRECTIONS
Philadelphia District Office (PHI-DO)
7/3/2013
62TCS07PANTOPRAZOLE SODIUM
16DIRECTIONS
Philadelphia District Office (PHI-DO)
7/3/2013
62TCS07PANTOPRAZOLE SODIUM
16DIRECTIONS
Philadelphia District Office (PHI-DO)
1/12/2012
61NCS24DOXEPIN HCL (ANTI-DEPRESSANT)
75UNAPPROVED
New Orleans District Office (NOL-DO)
8/18/2011
66QCS03PROBENECID (URICOSURIC)
16DIRECTIONS
Philadelphia District Office (PHI-DO)
5/12/2010
66SCS27NIFEDIPINE (VASODILATOR)
16DIRECTIONS
Minneapolis District Office (MIN-DO)
8/3/2009
66SIS51TADALAFIL
75UNAPPROVED
New Orleans District Office (NOL-DO)
4/10/2006
61LCS38CLOPIDOGREL BISULFATE (ANTI-COAGULANT)
75UNAPPROVED
Philadelphia District Office (PHI-DO)
6/9/2005
61JCS10FLUVASTATIN SODIUM (ANTI-CHOLESTEREMIC)
16DIRECTIONS
New York District Office (NYK-DO)
5/19/2005
66MCS86LORAZEPAM (TRANQUILIZER)
16DIRECTIONS
New York District Office (NYK-DO)
9/24/2004
64BCZ24FUROSEMIDE (DIURETIC)
16DIRECTIONS
New York District Office (NYK-DO)
9/21/2004
62ICS86LEUPROLIDE ACETATE (ANTI-NEOPLASTIC)
16DIRECTIONS
New York District Office (NYK-DO)

Frequently Asked Questions

What is Assia Chemical Industries Ltd - Teva Tech Site's FDA import refusal history?

Assia Chemical Industries Ltd - Teva Tech Site (FEI: 3002913672) has 14 FDA import refusal record(s) in our database, spanning from 9/21/2004 to 8/2/2016.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Assia Chemical Industries Ltd - Teva Tech Site's FEI number is 3002913672.

What types of violations has Assia Chemical Industries Ltd - Teva Tech Site received?

Assia Chemical Industries Ltd - Teva Tech Site has been cited for 2 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Assia Chemical Industries Ltd - Teva Tech Site come from?

All FDA import refusal data for Assia Chemical Industries Ltd - Teva Tech Site is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.